ORIC PHARMACEUTICALS, INC. (ORIC) Operating income 2018–2025
ORIC PHARMACEUTICALS, INC. (ORIC) annual operating income history from SEC filings — each fiscal year as reported.
-$143.0MFY2025 · since FY2018: -$22.4M → -$143.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$143.0M | -0.1% |
| FY2024 | -$142.9M | -29.0% |
| FY2023 | -$110.8M | -20.7% |
| FY2022 | -$91.8M | -16.4% |
| FY2021 | -$78.9M | -6.3% |
| FY2020 | -$74.2M | -159.7% |
| FY2019 | -$28.6M | -27.7% |
| FY2018 | -$22.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ORIC financial trends
ORIC RevenueORIC Net incomeORIC Net marginORIC Gross profitORIC Gross marginORIC Operating marginORIC Operating cash flowORIC Free cash flowORIC Capital expendituresORIC Return on equityORIC Stock buybacksORIC Dividends paidORIC Total assetsORIC Total liabilitiesORIC Shareholders’ equityORIC overview →